+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Molecular Diagnostic Market - Global Forecast 2026-2032- Product Image
Veterinary Molecular Diagnostic Market - Global Forecast 2026-2032- Product Image
Sale

Veterinary Molecular Diagnostic Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 4986086
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Molecular Diagnostic Market is projected to reach USD 1.49 Billion in 2026. It is expected to continue growing at a CAGR of 7.90%, reaching USD 2.35 Billion by 2032.

Veterinary molecular diagnostics is becoming a core pillar of modern animal health because it can identify pathogens, genetic markers, and antimicrobial resistance determinants with high analytical sensitivity and faster turnaround than many culture-based methods. Polymerase chain reaction (PCR), real-time quantitative PCR (qPCR), reverse transcription PCR, isothermal amplification, microarrays, and next-generation sequencing (NGS) are now used across companion animal care, livestock production, equine medicine, wildlife health, aquaculture, and food-animal biosecurity.

Demand is supported by structural disease pressure. The CDC reports that 6 in 10 known infectious diseases in people can spread from animals, while 3 in 4 new or emerging infectious diseases in people originate in animals. This zoonotic risk profile makes veterinary infectious disease testing, syndromic panels, antimicrobial resistance detection, and genomic surveillance strategically important for veterinarians, producers, public health agencies, and diagnostic laboratories.

The market’s center of gravity is shifting from reactive testing toward early detection, herd-level surveillance, precision treatment decisions, and integrated One Health monitoring. As pet ownership, livestock intensification, cross-border animal trade, and antimicrobial stewardship requirements expand, veterinary molecular diagnostic solutions are increasingly evaluated on accuracy, speed, workflow efficiency, sample-to-answer automation, regulatory compliance, and interoperability with laboratory information systems.

Transformative Shifts in the Veterinary Testing Landscape

The veterinary molecular diagnostics landscape is being reshaped by the convergence of rapid PCR platforms, multiplex panels, portable nucleic-acid testing, and sequencing-based epidemiology. Veterinary hospitals and reference laboratories are moving beyond single-pathogen tests to panels that can differentiate clinically similar respiratory, gastrointestinal, reproductive, and vector-borne diseases, enabling faster treatment, isolation, and biosecurity decisions.

Livestock and poultry producers are also adopting molecular testing to reduce economic losses linked to outbreaks, support vaccination strategies, and comply with trade and animal health rules. Diseases such as avian influenza, African swine fever, bovine respiratory disease complex, foot-and-mouth disease, and porcine reproductive and respiratory syndrome have reinforced the value of rapid detection and traceability across farms, transport networks, and processing environments.

A second major shift is decentralization. Point-of-care and near-patient molecular platforms are reducing reliance on distant laboratories for urgent decisions, while cloud-connected instruments improve result reporting and outbreak visibility. At the same time, laboratories continue to invest in automation, extraction-free workflows, high-throughput qPCR, and NGS to manage larger sample volumes and support genomic surveillance.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is cumulatively improving veterinary molecular diagnostics across assay development, workflow optimization, bioinformatics, and clinical decision support. AI-enabled primer and probe design can accelerate target selection by screening pathogen genomes for conserved and specific regions, reducing the risk of cross-reactivity and helping laboratories adapt when pathogens mutate.

In sequencing workflows, machine learning supports read classification, variant calling, antimicrobial resistance gene detection, and outbreak clustering. These capabilities are particularly relevant for One Health surveillance because animal, human, and environmental data must be interpreted together to identify transmission pathways and emerging risks.

AI is also changing laboratory operations. Predictive analytics can help forecast testing demand during seasonal respiratory disease, vector-borne disease, or food-animal outbreak cycles. Automated quality-control flags can identify extraction failure, inhibition, contamination patterns, or unusual positivity rates. For veterinarians, AI-assisted interpretation can support evidence-based test selection and antimicrobial stewardship, provided outputs remain transparent, validated, and supervised by qualified professionals.

Key Regional Insights Across Global Markets

North America remains one of the most advanced regions for veterinary molecular diagnostics due to strong companion animal spending, established reference laboratory networks, university veterinary hospitals, and government-supported animal disease surveillance. The United States benefits from infrastructure such as the National Animal Health Laboratory Network, while Canada’s surveillance ecosystem supports livestock, wildlife, and companion animal testing. Mexico’s role in livestock production and cross-border trade strengthens demand for rapid diagnostics that support biosecurity and market access.

Europe is shaped by stringent animal health, food safety, and antimicrobial stewardship expectations. The European Union’s Animal Health Law and coordinated surveillance approach encourage harmonized disease monitoring, while major veterinary markets such as Germany, France, Italy, Spain, and the United Kingdom maintain strong demand for PCR, qPCR, and sequencing services in companion animal and production animal settings. Russia’s large livestock base and transcontinental geography create continuing need for scalable animal disease diagnostics.

Asia-Pacific is expanding as pet ownership rises, livestock systems modernize, and governments invest in disease surveillance following repeated regional threats such as avian influenza and African swine fever. China, India, Japan, South Korea, and Australia represent distinct demand centers, ranging from large-scale food-animal testing to high-value companion animal diagnostics and advanced biosecurity programs. Latin America, led by Brazil and Mexico, is supported by export-oriented livestock and poultry industries where molecular testing strengthens certification, traceability, and outbreak response. The Middle East is investing in food security, equine health, falcon health, and camel disease diagnostics, while Africa’s long-term opportunity is tied to transboundary animal disease control, laboratory capacity building, and One Health programs for zoonotic disease monitoring.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, demand for veterinary molecular diagnostics is closely tied to poultry, swine, aquaculture, and emerging companion animal care. The region’s dense animal production systems and cross-border trade make rapid PCR and surveillance testing important for avian influenza, African swine fever, and other transboundary diseases. ASEAN laboratories are also increasingly relevant to food safety, import controls, and export certification.

The GCC market is shaped by food security strategies, high-value equine and falcon health, camel disease management, and growing companion animal care. Molecular diagnostics can support rapid outbreak response, quarantine decisions, and import screening in countries that depend heavily on animal and food imports. In the European Union, harmonized regulation, antimicrobial resistance monitoring, animal welfare expectations, and veterinary public health programs continue to strengthen demand for validated molecular assays and interoperable laboratory data.

BRICS countries represent a major strategic demand base because they combine large livestock populations, expanding pet care, and government interest in biosecurity. China, India, and Brazil are especially important due to the scale of animal agriculture and the need to protect trade-sensitive supply chains. G7 markets lead in premium companion animal diagnostics, advanced sequencing, laboratory automation, and regulatory quality systems. NATO countries are relevant from a biosecurity perspective because animal disease surveillance can intersect with food supply resilience, military working animal health, and protection against agroterrorism threats.

Key Country Insights in Veterinary Molecular Diagnostics

The United States leads adoption through large companion animal healthcare expenditure, reference laboratory scale, and federal-state animal disease surveillance. Canada emphasizes integrated surveillance and livestock health, while Mexico’s poultry, cattle, and swine industries support demand for fast, reliable testing. Brazil is a critical country for veterinary molecular diagnostics because it is a global leader in beef and poultry exports, making disease monitoring, certification, and biosecurity essential.

In Europe, the United Kingdom maintains strong companion animal and equine diagnostic demand, while Germany and France combine advanced veterinary care with major livestock sectors. Italy and Spain are important for companion animals, swine, poultry, and ruminant health. Russia’s large agricultural footprint and disease-control needs support continued use of molecular testing for production animals and transboundary disease risks.

China is a central growth market due to its vast swine and poultry industries, expanding pet care sector, and continued emphasis on biosecurity after African swine fever disruptions. India’s opportunity is anchored in dairy, poultry, companion animals, and public-sector disease surveillance. Japan and South Korea represent technologically advanced markets with strong quality expectations, aging pet populations, and high diagnostic standards, while Australia’s strict biosecurity environment and export-oriented livestock industry make molecular diagnostics essential for early detection, surveillance, and trade confidence.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated, workflow-efficient molecular diagnostic platforms that address high-burden disease categories in companion animals, livestock, poultry, aquaculture, and equine medicine. Multiplex respiratory, gastrointestinal, reproductive, and vector-borne disease panels can deliver strong value when they shorten time to diagnosis and guide treatment, isolation, and antimicrobial stewardship decisions.

Manufacturers and laboratories should invest in automation, contamination control, sample preparation simplification, cold-chain resilience, and connectivity with practice management and laboratory information systems. These capabilities improve throughput, reduce manual error, and support faster reporting during outbreak conditions. Providers should also design solutions that meet regional regulatory expectations and include robust quality-control documentation.

Strategic partnerships with veterinary schools, reference laboratories, public health agencies, producers, and distributors can accelerate adoption. Leaders should also build AI governance into product roadmaps by validating algorithms, documenting performance, protecting data privacy, and ensuring veterinarians remain central to clinical interpretation.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on verified sources in animal health, infectious disease, diagnostics, and public policy. Core inputs include publicly available information from organizations such as the World Organisation for Animal Health, the CDC, USDA, FDA, European Commission, EFSA, national animal health agencies, peer-reviewed journals, veterinary associations, and publicly available disclosures from diagnostic technology providers.

The analysis triangulates disease burden, regulatory direction, technology adoption, regional animal health infrastructure, and end-user demand across companion animal, livestock, poultry, equine, aquaculture, and wildlife applications. Market interpretation is grounded in observable drivers such as zoonotic disease risk, antimicrobial resistance monitoring, animal trade requirements, laboratory modernization, and the shift toward molecular and genomic surveillance.

All qualitative insights are reviewed for consistency, plausibility, and relevance to veterinary molecular diagnostics. No unsupported market-size, market-share, or forecast claims are used; the emphasis is on evidence-backed trends, technology adoption patterns, and strategic implications for decision-makers.

Conclusion

Veterinary molecular diagnostics is moving from a specialized laboratory service to a strategic component of animal health, public health, food security, and biosecurity. PCR, qPCR, isothermal amplification, and sequencing technologies are enabling faster and more precise detection of infectious diseases, genetic risks, and antimicrobial resistance markers across a widening set of animal populations.

The strongest opportunities will favor providers that combine validated assays, scalable workflows, regional regulatory alignment, and digital connectivity. AI will further improve assay design, surveillance analytics, and laboratory productivity, but adoption will depend on transparent validation, responsible data governance, and supervised clinical use.

As zoonotic disease risk, livestock trade, pet healthcare expectations, and One Health programs intensify, veterinary molecular diagnostics will remain a high-priority investment area for laboratories, veterinary providers, producers, governments, and diagnostic technology innovators.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Veterinary Molecular Diagnostic Market, by Product
7.1. Introduction
7.2. Consumables & Reagents
7.2.1. Enzymes
7.2.2. Kits
7.2.3. Probes & Primers
7.3. Instruments
7.3.1. PCR Instruments
7.3.2. Sequencers
7.4. Software & Services
8. Veterinary Molecular Diagnostic Market, by Technology
8.1. Introduction
8.2. Conventional PCR
8.3. Digital PCR
8.4. Isothermal Amplification
8.5. Microarray
8.6. Next-Generation Sequencing
8.6.1. Illumina Sequencing
8.6.2. Ion Torrent Sequencing
8.6.3. Oxford Nanopore
8.7. Real-Time PCR
9. Veterinary Molecular Diagnostic Market, by Animal Type
9.1. Introduction
9.2. Aquaculture
9.2.1. Fish
9.2.2. Shellfish
9.3. Avian
9.4. Companion Animals
9.4.1. Cats
9.4.2. Dogs
9.5. Livestock
9.5.1. Cattle
9.5.2. Poultry
9.5.3. Swine
9.6. Wildlife
10. Veterinary Molecular Diagnostic Market, by Disease Type
10.1. Introduction
10.2. Genetic Disorders
10.3. Infectious Diseases
10.3.1. Bacterial Infections
10.3.2. Fungal Infections
10.3.3. Parasitic Infections
10.3.4. Viral Infections
10.4. Oncology
11. Veterinary Molecular Diagnostic Market, by End User
11.1. Introduction
11.2. Academic Institutes
11.3. Diagnostic Centers
11.4. Reference Laboratories
11.5. Research Institutes
11.6. Veterinary Hospitals & Clinics
12. Veterinary Molecular Diagnostic Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Veterinary Molecular Diagnostic Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Veterinary Molecular Diagnostic Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Agilent Technologies, Inc.
16.2. Agrolabo S.p.A.
16.3. Antech Diagnostics, Inc.
16.4. Bio-Rad Laboratories, Inc.
16.5. Biomedica Medizinprodukte GmbH & Co. KG
16.6. bioMérieux S.A.
16.7. Bioneer Corporation
16.8. BioNote, Inc.
16.9. Generi Biotech s.r.o.
16.10. GZ MED Technology Co., Ltd.
16.11. HealthGene Corporation
16.12. Heska Corporation
16.13. IDEXX Laboratories, Inc.
16.14. INDICAL BIOSCIENCE GmbH
16.15. Ingenetix GmbH
16.16. Innovative Diagnostics SAS
16.17. LGC Limited
16.18. Merck KGaA
16.19. MiDOG Animal Diagnostics LLC
16.20. Neogen Corporation
16.21. Novacyt S.A.
16.22. PathoSense B.V.
16.23. QIAGEN N.V.
16.24. Randox Laboratories Ltd.
16.25. Ring Biotechnology Co., Ltd.
16.26. Seegene Inc.
16.27. Thermo Fisher Scientific Inc.
16.28. Veterinary Molecular Diagnostics, Inc.
16.29. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CONSUMABLES & REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CONSUMABLES & REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CONSUMABLES & REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL PROBES & PRIMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL PROBES & PRIMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL PROBES & PRIMERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL PCR INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL PCR INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL PCR INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL SEQUENCERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SEQUENCERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SEQUENCERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CONVENTIONAL PCR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CONVENTIONAL PCR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL CONVENTIONAL PCR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL DIGITAL PCR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL DIGITAL PCR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL DIGITAL PCR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ISOTHERMAL AMPLIFICATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ISOTHERMAL AMPLIFICATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ISOTHERMAL AMPLIFICATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL MICROARRAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL MICROARRAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL MICROARRAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL ILLUMINA SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL ILLUMINA SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL ILLUMINA SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL ION TORRENT SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL ION TORRENT SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL ION TORRENT SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL OXFORD NANOPORE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL OXFORD NANOPORE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL OXFORD NANOPORE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL REAL-TIME PCR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL REAL-TIME PCR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL FISH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL FISH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL FISH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL SHELLFISH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL SHELLFISH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL SHELLFISH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL AVIAN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL AVIAN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL AVIAN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL CATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL CATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL DOGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL DOGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL LIVESTOCK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL LIVESTOCK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL LIVESTOCK MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL CATTLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL POULTRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL SWINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL SWINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL WILDLIFE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL WILDLIFE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL WILDLIFE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL GENETIC DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL GENETIC DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL GENETIC DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2017-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 145. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 147. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2017-2032 (USD MILLION)
TABLE 148. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 149. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 150. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2017-2032 (USD MILLION)
TABLE 151. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 152. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 153. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 154. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 155. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 156. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 157. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 158. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 159. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 160. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2017-2032 (USD MILLION)
TABLE 161. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 162. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 163. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2017-2032 (USD MILLION)
TABLE 164. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 165. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 166. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 167. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 168. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 169. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 170. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 171. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 172. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 173. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2017-2032 (USD MILLION)
TABLE 174. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 175. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 176. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2017-2032 (USD MILLION)
TABLE 177. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 178. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 179. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 180. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 181. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 182. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 183. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 184. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 185. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 186. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2017-2032 (USD MILLION)
TABLE 187. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 188. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 189. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2017-2032 (USD MILLION)
TABLE 190. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 191. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 192. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 193. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 194. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 195. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 196. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 197. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 198. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 199. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2017-2032 (USD MILLION)
TABLE 200. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 201. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 202. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2017-2032 (USD MILLION)
TABLE 203. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 204. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 205. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 206. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 207. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 208. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 209. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 210. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 211. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 212. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 213. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2017-2032 (USD MILLION)
TABLE 214. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 215. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 216. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2017-2032 (USD MILLION)
TABLE 217. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 218. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 219. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 220. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 221. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 222. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 223. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 224. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 225. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 226. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2017-2032 (USD MILLION)
TABLE 227. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 228. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 229. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2017-2032 (USD MILLION)
TABLE 230. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 231. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 232. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 233. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 234. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 235. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 236. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2017-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 250. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 251. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 252. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2017-2032 (USD MILLION)
TABLE 253. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 254. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 255. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2017-2032 (USD MILLION)
TABLE 256. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 257. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 258. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 259. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 260. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 261. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 262. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 263. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 264. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 265. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2017-2032 (USD MILLION)
TABLE 266. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 267. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 268. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2017-2032 (USD MILLION)
TABLE 269. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 270. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 271. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 272. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 273. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 274. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 275. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 276. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 277. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 278. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2017-2032 (USD MILLION)
TABLE 279. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 280. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 281. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2017-2032 (USD MILLION)
TABLE 282. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 283. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 284. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 285. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 286. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 287. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 288. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 289. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 290. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 291. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2017-2032 (USD MILLION)
TABLE 293. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 294. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 295. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2017-2032 (USD MILLION)
TABLE 296. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 297. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 298. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 299. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 300. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 301. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 302. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 303. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 304. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 305. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2017-2032 (USD MILLION)
TABLE 306. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 307. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 308. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2017-2032 (USD MILLION)
TABLE 309. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 310. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 311. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 312. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 313. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 314. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 315. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 316. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 317. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 318. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2017-2032 (USD MILLION)
TABLE 319. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 320. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 321. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2017-2032 (USD MILLION)
TABLE 322. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 323. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 324. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 325. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 326. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 327. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 328. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 329. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 330. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 331. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2017-2032 (USD MILLION)
TABLE 332. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 333. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 334. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2017-2032 (USD MILLION)
TABLE 335. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 336. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 337. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 338. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 339. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2017-203

Companies Mentioned

  • Agilent Technologies, Inc.
  • Agrolabo S.p.A.
  • Antech Diagnostics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biomedica Medizinprodukte GmbH & Co. KG
  • bioMérieux S.A.
  • Bioneer Corporation
  • BioNote, Inc.
  • Generi Biotech s.r.o.
  • GZ MED Technology Co., Ltd.
  • HealthGene Corporation
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • INDICAL BIOSCIENCE GmbH
  • Ingenetix GmbH
  • Innovative Diagnostics SAS
  • LGC Limited
  • Merck KGaA
  • MiDOG Animal Diagnostics LLC
  • Neogen Corporation
  • Novacyt S.A.
  • PathoSense B.V.
  • QIAGEN N.V.
  • Randox Laboratories Ltd.
  • Ring Biotechnology Co., Ltd.
  • Seegene Inc.
  • Thermo Fisher Scientific Inc.
  • Veterinary Molecular Diagnostics, Inc.
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.49 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.35 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Veterinary Molecular Diagnostics - Global Strategic Business Report - Product Image

Veterinary Molecular Diagnostics - Global Strategic Business Report

  • Report
  • 570 Pages
  • Global
From
Veterinary Molecular Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2026-2034 - Product Image

Veterinary Molecular Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2026-2034

  • Report
  • 140 Pages
  • Global
From
Veterinary Molecular Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Veterinary Molecular Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Veterinary Molecular Diagnostics Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Veterinary Molecular Diagnostics Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Veterinary Molecular Diagnostics Market Report 2026 - Product Image

Veterinary Molecular Diagnostics Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Veterinary Molecular Diagnostic Market

The Veterinary Molecular Diagnostic market is a subset of the Animal Healthcare/Veterinary industry. It focuses on the use of molecular diagnostics to detect and diagnose diseases in animals. This includes the use of genetic testing, PCR testing, and other molecular techniques to identify and monitor diseases in animals. Veterinary Molecular Diagnostics can be used to detect and diagnose a wide range of diseases, including infectious diseases, genetic disorders, and cancer. It can also be used to monitor the effectiveness of treatments and to identify drug resistance. The Veterinary Molecular Diagnostic market is growing rapidly, driven by the increasing demand for animal healthcare services and the need for more accurate and reliable diagnostic tests. This market is expected to continue to grow in the coming years, as more advanced technologies become available. Some companies in the Veterinary Molecular Diagnostic market include IDEXX Laboratories, Inc., Neogen Corporation, Abaxis, Inc., and Zoetis, Inc. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.